Gordon Elisa J, Prohaska Thomas R, Sehgal Ashwini R
Alden March Bioethics Institute, Albany Medical Center, Albany, NY 12208, USA.
Clin Transplant. 2008 Nov-Dec;22(6):738-48. doi: 10.1111/j.1399-0012.2008.00869.x. Epub 2008 Jul 31.
This study aimed to examine kidney transplant recipients' ability to afford transplant-related out-of-pocket expenses and the financial impact of these expenses on their lives.
This cross-sectional study involved 77 kidney recipients. Variables analyzed were: ability to afford daily necessities; impact of immunosuppressant expenses on patients' lives; awareness of Medicare support terminating three yr post-transplant; and strategies used to pay for out-of-pocket transplant expenses. The Economic Strain Scale measured financial strain.
Twenty-nine percent of kidney recipients experienced financial strain. Poor, less educated, and younger patients were more likely to report financial strain. Out-of-pocket expenses relating to kidney transplantation adversely affected patients' ability to afford leisure activities (35%), a house (27%), and a car (26%). Thirty-one percent reported that immunosuppressant expenses have had somewhat to great (adverse) impact on their lives. Of those on Medicare and not disabled (n = 41), 51% were unaware Medicare coverage will terminate and 71% did not know how long coverage lasts.
Financial strain presents a considerable risk to kidney recipients' ability to purchase immunosuppression. Socioeconomic disparities in recipients' financial strain may be a source of disparities in graft survival. Transplant professionals should better inform transplant candidates about financial consequences of transplantation.
本研究旨在调查肾移植受者支付与移植相关的自付费用的能力,以及这些费用对其生活的经济影响。
这项横断面研究纳入了77名肾移植受者。分析的变量包括:购买生活必需品的能力;免疫抑制剂费用对患者生活的影响;对移植后三年医疗保险支持终止的知晓情况;以及支付移植自付费用所采用的策略。经济压力量表用于衡量经济压力。
29%的肾移植受者经历了经济压力。贫困、受教育程度较低和较年轻的患者更有可能报告经济压力。与肾移植相关的自付费用对患者进行休闲活动(35%)、购买住房(27%)和汽车(26%)的能力产生了不利影响。31%的患者报告免疫抑制剂费用对他们的生活有一定到很大程度(不利)的影响。在参加医疗保险且未残疾的患者(n = 41)中,51%的人不知道医疗保险覆盖范围会终止,71%的人不知道覆盖期限有多久。
经济压力对肾移植受者购买免疫抑制剂的能力构成了相当大的风险。受者经济压力方面的社会经济差异可能是移植肾存活差异的一个来源。移植专业人员应更好地告知移植候选人有关移植的经济后果。